Brain reward circuits in alcoholism

CNS Spectrums

Volumn 4, Issue 1, 1999, Pages 23-37

  Koob, George F ^a   Roberts, Amanda J ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CORTICOTROPIN RELEASING FACTOR; N METHYL DEXTRO ASPARTIC ACID; NEUROTRANSMITTER;

ALCOHOL CONSUMPTION; ALCOHOL TOLERANCE; ALCOHOLISM; AMYGDALOID NUCLEUS; ARTICLE; BEHAVIOR DISORDER; HUMAN; NERVE CELL MEMBRANE; NERVE CONDUCTION; NEUROCHEMISTRY; PRIORITY JOURNAL; REINFORCEMENT; RELAPSE; REWARD; SYNDROME;

EID: 0032938057     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/S1092852900011196     Document Type: Article

References (146)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association Press; 1991.
2. Wikler A. Dynamics of drug dependence: implications of a conditioning theory for research and treatment. Arch Ccn Psychiatry. 1973;28:611-616.
3. Koob GF, Markou A, Weiss F, Schulteis G. Opponent process and drug dependence: neurobiological mechanisms. Semin Neurosci. 1993;5:351-358.
4. Schuster CR, Thompson T. Self administration and behavioral dependence on drugs. Anna Rev Pharmacol Toucol. 1969;9:483-502.
5. Samson HH. Initiation of ethanol reinforcement using a sucrose-substitution procedure in food- and water-sated rats. Alcohol Clin Exp Res. 1986;10:436-442.
6. Olds J, Milner P. Positive reinforcement produced by electrical stimulation of septal area and other regions of rat brain. J Comp Physiol Psychol. 1954;47:419-427.
7. Komelsky C, Esposito RU. Euphorigenic drugs: effects on the reward pathways of the brain. Federation Proc. 1979;38:2473-2476.
8. Marken A, Koob GF. Postcocaine anhedonia: an animal model of cocaine withdrawal, h'europsychopharmacology. 1991;4:17-26.
9. Schulteis G, Markou A, Gold LH, Stinus L, Koob GF. Relative sensitivity to naloxone of multiple indices of opiate withdrawal: a quantitative dose-response analysis. / Pharmacol Exp Ther. 1994;271:1391-1398.
10. Ieith NJ, Barrett RJ. Amphetamine and the reward system: evidence for tolerance and post-drug depression. Psychopharmacologia. 1976;46:19-25.
11. Parsons LH, Koob GF, Weiss F. Serotonin dysfunction in the nucleus accumbens of rats during withdrawal after unlimited access to intravenous cocaine. J Pharmacol ExpTher. 1995;274:'ll82-1191.
12. Epping-Jordan MP, Watkins SS, Koob GF, Markou A. Dramatic decreases in brain reward function during nicotine withdrawal. Nature. 1998;393:76-79.
13. Legaull M, Wise RA. Effects of withdrawal from nicotine on intracranial self-stimulation. Neurosd Abstr. 199420:1032.
14. Schulteis G, Markou A, Cole M, Koob GF. Decreased brain reward produced by ethanol withdrawal. Proc Natl AcadSci USA. 1995;92:5880-5884.
15. Markou A, Kosten TR, Koob GF. N'eurobiological similarities in depression and drug dependence: a self-medication hypothesis. Neuropsychophannacology. 1998;18:135-174.
16. Ileyser CJ, Schulteis G, Durbin P, Koob GF. Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats. Ncuropsychopharmacology. 1998;18:125-133.
17. Samson HH. Initiation of ethanol-maintained behavior: a comparison of animal models and their implication for human drinking. In: Thompson T, Dews PB, Barren JE, eds. Ncurobeharioral Pharmacology. Hillsdale, NJ: Lawrence Erlbaum; 1987:221-248.
18. Samson HH, Pfeffer AO, Tolliver GA. Oral ethanol selfadministration in rats: models of alcohol-seeking behavior. ,1/co/io/ Clin Exp Res. 1988;12:591-598.
19. Samson HH, Hodge CW, Tolliver GA, Haraguchi M. Effect of dopamine agonists and antagonists on ethanolreinforced behavior: the involvement of the nucleus accumbens. Brain Res Bull. 1993;30:133-141.
20. Tabakoff B, Hoffman PL. Alcohol: neurobiology. In: Lowinson JH, Ruiz P, Millman RB, eds. Substance Abuse: A Comprehensive Textbook. 2nd ed. Baltimore, MD: Williams & Wilkins; 1992:152-185.
21. Deilrich RA, Dunwiddie TV, Harris RA, Erwin VG. Mechanism of action of ethanol: initial central nervous system actions. Pharmacol Rei: 1989;41:489-537.
22. Hyytia P, Koob GF. GABA receptor antagonism in the extended amygdala decreases ethanol self-administration in rats. Eur J Pharmacol. 1995;283:151-159.
23. Rassnick S, Pulvirenti L, Koob GF. Oral ethanol self-administration in rats is reduced by the administration of dopamine and glutamate receptor antagonists into the nucleus accumbens. Psychopharmacology. 1992;109:92-98.
24. Weiss F, Hurd YL, Ungersledt U, Markou A, Plotsky PM, Koob GF. N'eurochemical correlates of cocaine and ethanol self-administration. Ann i\Y AcadSci. 1992;651:220-241.
25. Rassnick S, Stinus L, Koob GF. The effects of 6hydroxydopamine lesions of the nucleus accumbens and the mesolimbic dopamine system on oral self-administration of ethanol in the rat. Brain Res. 1993;623:16-24.
26. Murai T, Koshikawa N, Kanayama T, Takada K, Tomiyama K, Kobayashi M. Opposite effects of midazolam and beta-carboline-3-carboxylate ethyl ester on the release of dopamine from rat nucleus accumbens measured by in vivo microdialysis. Eur J Pharmacol. 1994;261:65-71.
27. Engel JA, Enerback C, Fahlke C, et al. Serotonergic and dopaminergic involvement in ethanol intake. In: Naranjo CA, Sellers EM, eds. Noi-el Pharmacological Interventions for Alcoholism. New York, NY: Springer-Verlag: 1992:68-82.
28. Heyser CJ, Roberts AJ, Schulteis G, Hyytia P, Koob GF. Central administration of an opiate antagonist decreases oral ethanol self-administration in rats. Xeurosci Abstr. 1995;21:1698.
29. Zabik JE, Blinkerd K, Roache JD. Serotonin and ethanol aversion in the rat. In: Naranjo CA, Sellers EM, eds. Research Advances in I\'eic Psychopharmacological Treatments for Alcoholism. New York, NY: Excerpta Medica; 1985:87-100.
30. Fadda F, Garau B, Marchei F, Colombo G, Cessa GL. MDL 72222, a selective 5-HT3 receptor antagonist, suppresses voluntary ethanol consumption in alcohol-preferring rals./1/conoZ/l/co/ioJ. 1991;26:107-110.
31. Hodge CW, Samson HH, Lewis RS, Erickson HL. Specific decreases in ethanol-but not water-reinforced responding produced by the 5-HT3 antagonist ICS 205-930. Alcohol. 1993;10:191-196.
32. Grant KA, Barrett JE. Blockade of the discriminative stimulus effects of ethanol with 5-HT3 receptor antagonists. Psychopharmacology. 1991;104:451-456.
33. Roberts AJ, McArthur RA, Hull EE, Post C, Koob GF. Effects of amperozide, 8-OH-DPAT, and FG 5974 on opérant responding for ethanol. Psychopharmacology. 1998;137:25-32.
34. Huffman PL, Rabe C, Moses F, Tabakoff B. A'-methyl-ûaspartate receptors and ethanol: inhibition of calcium flux and cyclic GMP production. J Neurochcm. 1989;52:1937-1940.
35. Lovinger DM, ''bite G, Weight FF. Elhanol inhibits NMDA-activated ion current in hippocampal neurons. Science. 1989;243:1721-1724.
36. Grant KA, Colombo G. Discriminative stimulus effects of ethanol: effect of training dose on the substitution of A'-methyl-D-aspartate antagonists. J Pharmacol Exp Ther. 1993;264:1241-1247.
37. Fitzgerald LW, Nestler EJ. Molecular and cellular adaptations in signal transduction pathways following etbanol exposure. Clin Neiirosci. 1995;3:165-173.
38. Koob GF, Rassnick S, Heinrichs S, Weiss F. Alcohol, the reward system and dependence. In: Jansson B, Jörnvall II, Rydberg U, Terenius L, Vallée BL, eds. Toward a Molecular Basis of Alcohol Use and Abuse. Boston, Mass: Birkhauser-Verlag; 1994:103-114.
39. Thiele TE, Marsh DJ, Ste. Marie L, Bernstein IL, Palmiter RD. Ethanol consumption and resistance are inversely related to neuropeplide y levels. Nature. 1998;396:366-369.
40. Koob GF. Drugs of abuse: anatomy, pharmacology, and function of reward pathways. Trends Pharmacol Sei. 1992;13:177-iat.
41. Mereu G, Fadda F, Cessa GL. Ethanol stimulates the firing rate of nigral dopaminergic neurons in unanesthetized rats. Brain Res. 1984;292:63-69.
42. Weiss F, Lorang MT, Bloom FE, Koob GF. Oral alcohol self-administration stimulates dopamine release in the rat nucleus accumbens: genetic and motivational determinants. J Pharmacol Exp Ther. 1993;267:250-258.
43. Givens BS, Breese GR. Site-specific enhancement of gamma-aminobutyric acid-mediated inhibition of neural activity by ethanol in the rat medial septal area. } Pharmacol Exp Ther. 1990;254:528-538.
44. Koob GF, Sanna PP, Bloom FE. Neuroscienee of addiction. Neuron. 1998;21?467-476.
45. Koob GF, Robledo P, Marlcou A, Caine SB. The mesocorticolimbic circuit in drug dependence and reward: a role for the extended amygdala? In: Kalivas PW, Bames CD, eds. Limbic Motor Circuits and Neuropsychiatry. Boca Raton, Fla: CRC Press; 1993:289-309.
46. Koob GF, Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Science. 1997;278:52'58.
47. Koob GF. Drug addiction: the yin and yang of hedonic homeostasis. Neuron. 1996;16:893-896.
48. Russell MAIL What is dependence? In: Edwards G, Russell MAH, Hawks D, MacCafferty M, eds. Drugs and Drug Dependence. Lexington, Mass: Lexington Books; 1976:182-187.
49. Markou A, Koob GF. Construct validity of a self-stimulation threshold paradigm: effects of reward and performance manipulations. Pliysiol Behav. 1992;51:111-119.
50. Robinson TE, Berridge KC. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev. 1993;18:247-291.
51. Solomon RL, Corbit JD. An opponent-process theory of motivation. I: temporal dynamics of affect. Psychol Rev. 1974;81:119-145.
52. Siegel S. Evidence from rats that morphine tolerance is a learned response. J Comp Physiol Psychol. 1975;89:498-506.
53. Poulos CX, Cappell H. Homeostatic theory of drug tolerance: a general model of physiological adaptation. Psychol Rev. 1991;98:390-408.
54. Koob GF, Bloom FE. Cellular and molecular mechanisms of drug dependence. Science. 1988;242:715-723.
55. Weiss F, Markou A, Lorang MT, Koob GF. Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimitedaccess self-administration. Brain Res. 1992;593:314-318.
56. Roberts AJ, Cole M, Koob GF. Intra-amygdala muscimol decreases opérant ethanol self-administration in dependent rats. Alcohol Clin Exp Res. 1996;20:1289-1298.
57. Weiss F, Parsons LH, Schulteis G, et al. Ethanol selfadministration restores withdrawal-associated deficiencies in accumbal dopamine and 5-hydroxytryptamine release in dependent rats. J Neurosci. 1996; 16:3474-3485.
58. Kreek MJ. Multiple drug abuse patterns and medical consequences. In: Meltzer HY, ed. Psychopharmacology: The Third Generation of Progress. New York, NY: Raven Press; 1987:1597-1604.
59. Kreek MJ, Ragunath J, Plevy S, Hamer D, Schneider B, Hartman N. ACTH, Cortisol and beta-endorphin response to metyrapone testing during chronic methadone maintenance treatment in humans. Neunpeptides. 1984;5:277-278.
60. Koob GF, Heinrichs SC, Menzaghi F, Merlo-Pich E, Britton KT. .Corticotropin-releasing factor, stress and behavior. Semin Neurosci. 1994;6:221-229.
61. Heinrichs SC, Menzaghi F, Schulteis G, Koob GF, Stinus L. Suppression of corticotropin-releasing factor in the amygdala attenuates aversive consequences of morphine withdrawal. Behav Pharmacol. 1995;6:74-80.
62. Rodriguez de Fonseca F, Carrera MRA, Navarro M, Koob GF, Weiss F. Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science. 1997;276:2050-2054.
63. Richter RM, Weiss F. In vivo CRF release in rat amygdala is increased during cocaine withdrawal in selfadministrating rats. S)Tiapse. In press.
64. 64.'Rassnick S, Heinrichs SC, Britton KT, Koob GF. 1 Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-Iike effects of ethanol withdrawal. Brain Res. 1993;605:25-32.
65. Sarnyai Z, Biro E, Gardi J, Vecsernyes M, Julesz J, Telegdy G. Brain corticotropin-releasing factor mediates "anxiety-like" behavior induced by cocaine withdrawal in rats. Brain Res. 1995;675:89-97.
66. Morrow AL, Suzdak PD, Karanian JW, Paul SM. Chronic ethanol administration alters gamma-aminobutyric acid, pentobarbital and ethanol-mediated 36Cl-uptake in cerebral cortical synaptoneurosomes. J Pharmacol Exp Ther. 1988;246:158-164.
67. Karobath M, Rogers J, Bloom FE. Benzodiazepine receptors remain unchanged after chronic ethanol administration. Neuropharmacology. 1980;19:125-128.
68. Mhatre MC, Pena G, Sieghart W, Ticku MK. Antibodies specific for GABA-A receptor alpha subunits reveal that chronic alcohol treatment down-regulates alpha-subunit expression in rat brain regions. J Neurochem. 1993;61:1620-1625.
69. Devaud LL, Smith FD, Grayson DR, Morrow AL. Chronic ethanol consumption differentially alters the expression of gamma-aminobutyric acidA receptor subunit mRNAs in rat cerebral cortex: competitive, quantitative reverse transcriptase-polymerase chain reaction analysis. Mol Pharmacol. 1995;48:861-868.
70. Tabakoff B, Hoffman PL. Alcohol addiction: an enigma among us. Neuron. 1996;16:909-912.
71. Devaud LL, Fritschy JM, Sieghart W, Morrow AL. Bidirectional alterations of GABAA receptor subunit peptide levels in rat cortex during chronic elhanol consumption and withdrawal. / Neurochem. 1997;69:126-130.
72. Mahmoudi M, Kang MH, Tillakaratne N, Tobin AJ, Olsen RW. Chronic intermittent ethanol treatment in rats increases GABA receptor
73. Charlton ME, Sweetnam PM, Fitzgerald LW, Terwilliger RZ, Nestler EJ, Duman RS. Chronic ethanol administration regulates the expression of GABAA receptor a 1 and a 5 subunits in the ventral tegmental area and hippocampus. J Neurochem. 1997;68:121-127.
74. Trevisan L, Fitzgerald LW, Brose N, et al. Chronic ingestion of ethanol up-regulates NMDA-R1 receptor subunit immunoreactivity in rat hippocampus. J Neurochem. 1994;62:1635-1638.
75. Hu XJ, Ticku MK. Chronic elhanol treatment upregulates the NMDA receptor function and binding in mammalian cortical neurons. Mol Brain Res. 1995;30:347-356.
76. Chandler LJ, Sutton G, Norwood D, Sumners C, Crews FT. Chronic ethanol increases N-methyl-D-aspartate-stimulated nitric oxide formation but not receptor density in cultured cortical neurons. Mol Pharmacol. 1997:51:733-740.
77. Rossetti ZL, Catboni S. Ethanol withdrawal is associated with increased extracellular glutamate in the rat striatum. EUT]Pharmacol. 1995;283:177-183.
78. Ortiz J, Fitzgerald LW, Charlton M, et al. Biochemical actions of chronic ethanol exposure in the mesolimbic dopamine system. Synapse. 1995;21:289-298.
79. Messing RO, Petersen PJ, Henrich CJ. Chronic ethanol exposure increases levels of protein kinase C delta and epsilon and protein kinase C-mediated phosphor) lation in cultured neural cells JBiol Chem. 1991266:23428-23432.
80. Messing RO, Sneade AB, Savidge B. Protein kinase C participates in upregulation of dihydropyridine-sensitive calcium channels by ethanol. / A'eurocAwn. 1990;55:1383-1389.
81. Watson WP, Little JJ. Effects of dihydropyridines on the components of the ethanol withdrawal syndrome: possible evidence for involvement of potassium, as well as calcium? Alcohol Clin Exp Res. 1997;21:409-416.
82. Colombo G, Agabio R, Lobina C, et al. Effects of the calcium channel antagonist darodipine on ethanol withdrawal in rals. Alcohol Alcohol. 1995;30:125-131.
83. Shindou T, Watanabe S, Kamata 0, Yamamoto K, Nakanishi H. Calcium-dependent hyperexcitability of hippocampal CA1 pyramidal cells in an in vitro slice after ethanol withdrawal of the rat. Brain Res. 1994;656:432-436.
84. Diana M, Pistis M, Muntoni AL, Cessa GL. Ethanol withdrawal does not induce a reduction in the number of spontaneously active, dopaminergic neurons in the mesolimbic system. Brain Res. 1995;682:29-34.
85. Ryabinin AE, Criado JR, Henriksen SJ, Bloom FE, Wilson MC. Differential sensitivity of c-Fos expression in hippocampus and other brain regions to moderate and low doses of alcohol. Mol Psychiatry. 1997;2:32-43.
86. Koob GF, Wall TL, Schafer J. Rapid induction of tolerance to the antipunishment effects of ethanol. Alcohol. 1987;4:481-484.
87. Li DH, Depoortere RY, Emmett-Oglesby MW. Tolerance to the reinforcing effects of cocaine in a progressive ratio paradigm. Psychopharmacology. 1994;! 16:326-332.
88. Young AM, Goudie AJ. Adaptive processes regulating tolerance to the behavioral effects of drugs. In: Bloom FE, Kupfer DJ, eds. Psychopharmacology: The Fourth Generation of Progress. New York, NY: Raven Press; 1995:733-742.
89. Khanna JM, Kalant H, Shah G, Chau A. Effect of (+)MK801 and ketamine on rapid tolerance to ethanol. Brain Res Bull. 1992;283l 1-314.
90. Khanna JM, Morato GS, Chau A, Shah G, Kalant H. Effect of NMDA antagonists on rapid and chronic tolerance to ethanol: importance of intoxicated practice. Pharmacol Biochem Behav. 1994;48:755-763.
91. Collingridge GL, Singer W. Excitatory amino acid receptors and synaptic plasticity. Trends Pharmacol Sei. 1990;ll:290-296.
92. Huffman PL. Neuroadaptive functions of the neuropeptide arginine vasopressin: ethanol tolerance. In: Strand FL, Beckwith B, Chronwall B, Sandman CA, eds. Models of Neuropeptide Action. New York, NY: New York Academy of Sciences; 1994:168-175.
93. Szabo G, Tabakoff B, Huffman PL Receptors with VI characteristics mediate the maintenance of ethanol tolerance by vasopressin. J Pharmacol Exp Tlier. 1988247:536-541.
94. Szabo G, Nunley KR, Huffman PL Antisense oligonucleotide to c-fos blocks the ability of arginine vasopressin to maintain ethanol tolerance. Eur] Pharmacol 1996;306:67-72.
95. Nestler EJ, Hope BT, Widnell KL. Drag addiction: a model for the molecular basis of neural plasticity. Neuron. 1993;11:995-1006.
96. Krauss SW, Ghirnikar RB, Diamond I, Gordon AS. Inhibition of adenosine uptake by ethanol is specific for one class of nucleoside transporters. Mol Pharmacol. 1993;44:1021-1026.
97. Nag)' LE, Diamond I, Casso DJ, Franklin C, Gordon AS. Ethanol increases extracellular adenosine by inhibiting adenosine uptake via the nucleoside transporter. / Biol Chem. 1990;265:1946-1951.
98. Coe IR, Dohrman DP, Constantinescu A, Diamond I, Gordon AS. Activation of cyclic AMP-dependent protein kinase reverses tolerance of a nucleoside transporter to ethanol. J Pharmacol Exp Ther. 1996;276:365-369.
99. Coe IR, Yao L, Diamond I, Gordon AS. The role of protein kinase C in cellular tolerance to ethanol. J Biol Chem. 19%;271:29468-29472.
100. Phillips TJ, Feller DJ, Crabbe JC. Selected mouse lines, alcohol and behavior. Experientia. 1989;45:805-827.
101. Phillips TJ, Roberts AJ, Lessov CN. Behavorial sensitization to ethanol: genetics and the effects of stress. Pharmacol Biochem Behav. 1997;57:487-493.
102. Wise RA, Leeb K. Psychomotor-stimulant sensitization: a unitary phenomenon? Behav Pharmacol. 1993;4:339-349.
103. Koechling UM, Smith BR, Amit Z. Differential effects of catecholamine antagonists on elhanol-induced excitation in mice. Psychopharmacology. 1990;102:234-238.
104. Kalivas PW, Slewart J. Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity. Brain Res Rev. 1991;16:223-244.
105. White FJ, Wolf ME. Psychomotor stimulants. In: Prall JA, ed. The Biologkai Bases of Drug Tolerance and Dependence. London, England: Academic Press; 1991:153-197.
106. Henry DJ, White FJ. Repeated cocaine administration causes persistent enhancement of Dl dopamine receptor sensitivity within the rat nucleus accumbens. J Pharmacol Exp Ther. 1991;258:882-890.
107. Koob GF, Cador M. Psychomotor stimulant sensitization: the corticotropin-releasing factor-steroid connection. Behav Pharmacol. 1993;4:351-354.
108. Karler R, Calder LD, Chaudhry IA, Turkanis SA. Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801. Life Sei. 1989;45:599-606.
109. Wise RA. The neurobiology of craving: implications for the understanding and treatment of addiction. J Abnorm Psychol. 1988;97:118-132.
110. Ballenger JC, Post RM. Kindling as a model for alcohol withdrawal syndromes. Br J Psychiatry. 1978;133:1-14.
111. Becker HC, Diaz-Granados JL, Weathersby RT. Repeated ethanol withdrawal experience increases the severity and duration of subsequent withdrawal seizures in mice. Alcohol. 1997;14:319-326.
112. Kokka N, Sapp DW, Taylor AM, Olsen RW. The kindling model of alcohol dependence: similar persistent reduction in seizure threshold to pentylenetetrazol in animals receiving chronic ethanol or chronic pentylenetetrazol. Alcohol Clin Exp Res. 1993;17:525-531.
113. Decker HC, Hale RL Repeated episodes of ethanol withdrawal potentiate the severity of subsequent withdrawal seizures: an animal model of alcohol withdrawal "kindling." Alcohol Clin Exp Res. 1993;17:94-98.
114. Ulrichsen J, Becli B, Allemp P, Hemmingsen R. Diazepain prevents progression of kindled alcohol withdrawal behaviour. Psychopharmacology. 1995;121:451-160.
115. Kang M, Spigelman I, Sapp DW, Olsen RW. Persistent reduction of GABAA receptor-mediated inhibition in rat hippocampus after chronic intermittent ethanol treatment. Brain Res. 19%;709:221-228.
116. Hope BT, Nye HE, Kelz MB, et al. Induction of a long-lasting AP-1 complex composed of altered Fos-Iike proteins in brain by chronic cocaine and other chronic treatments. Keuron. 1994;13:1235-1244.
117. Hyman SE. Addiction to cocaine and amphetamine. Keuron. 1996;16:901-904.
118. Widnell K, Self DV, Lane SB, et al. Regulation of CREB expression: in vivo evidence for a functional role in morphine action in the nucleus accumbens. J Pharmacol Exp Ther. 1996;276:306-315.
119. Müller N, Hoehe M, Klein HE, et al. Endocrinological studies in alcoholics during withdrawal and after abstinence. Psychoneuroendocrinology. 1989;14:113-123.
120. Costa A, Bono G, Martignoni E, Merlo P, Sances G, Nappi G. An assessment of hypothalamo-pituitary| adrenal axis functioning in non-depressed, early ! abstinent alcoholics. Psychoneuroendocrinology. 1996;21:263-275.
121. : 121. Koob GF. Animal models of drug addiction. In: Bloom ! FE, Kupfer DJ, eds. Psychopharmacology: The Fourth Generation of Progress. New York, NY: Raven Press; 1995:759-772.
122. deWit H, Stewart J. Reinstatement of cocaine-reinforced responding in the rat. Psychopharmacology. 1981;75:134-143.
123. Stewart J, deWit H. Reinstatement of drug-taking behavior as a method of assessing incentive motivational properties of drugs. In: Bozarlh MA, ed. Methods of Assessing the Reinforcing Properties of Abused Drugs. New York, NY: Springer-Verlag; 1987:211-227.
124. Manley SJ, Little HJ. Enhancement of amphetamineand cocaine-induced locomotor activity after chronic ethanol administration. J Pharmacol Exp Ther. 1997;281:1330-1339.
125. Roberts AJ, Koob GF. Increased opérant responding for ethanol in rats with a prior history of dependence. Alcohol Clin Exp Res. 1996;20(suppl):22A.
126. Roberts AJ, Heyser CJ, Griffin P, Cole M, Koob GF. Opérant responding for ethanol after chronic ethanol vapor exposure in rats. Alcohol Clin Exp Res. 1997;21(suppl):43A.
127. Koob GF, Carrera MRA, Gold LU, et al. Substance dependence as a compulsive behavior. J Psychopharmacol. 1998;12:39-48.
128. Heyser CJ, Schulteis G, Durbin P, Koob GF. Clironic acamI prosate eliminates the alcohol deprivation effect while hav! ing limited effects on baseline responding for ethanol in ; rats. Neuropsychophamacology. 1998;18:125-133. :
129. Spanagel R, Zieglgansberger W. Anti-craving compounds I for ethanol: new pharmacological tools to study addictive processes. Trends Pharmacol Sei. 1997;18:5J-59. ;
130. Holler SM, Landgraf R, Zieglgansberger W, Spanagel j R. Time course of acamprosate action on opérant ! ethanol self-administration after ethanol deprivation. Alcohol Clin Exp Res. 1997;21:862-868.
131. Heyser CJ, Schulleis G, Koob GF. Increased ethanol self-administration after a period of imposed ethanol deprivation in rats trained in a limited access paradigm. Alcohol Clin Exp Res. 1997;21:784-791.
132. Madamba SG, Schweitzer P, Zieglgansberger W, Siggins GR. Acamprosate (calcium acetylhomotaurinate) enhances the N-methyl-D-aspartate component of excitatory neurotransmission in rat hippocampal CA1 neurons in vitro. Alcohol Clin Exp Res. 1996;20:651-658.
133. Zeise ML, Kasparov S, Capogna M, Zieglgansberger W. Acamprosate (calcium acetylhomotaurinate) decreases postsynaptic potentials in the rat neocortex: possible ex involvement of excitator)' amino acid receptors. Eur J Pharmacol. 1993;231:47-52. ulti
134. Volpicelli JR, Davis MA, Olgin JE. Naltrexone blocks the post-shock increase of ethanol consumption. Life Sei. 1986;38:811-847.
135. O'Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B. N'altrexone and coping skills therapy for alcohol dependence: a controlled study. Arch Gen Psychiatry. 1992;49:881-887.
136. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry. 1992;49:876-880.
137. Alheid GF, Heimer L. New perspectives in basal fore- < brain organization of special relevance for neuropsychiatrie disorders: the striatopallidal, amygdaloid, and corticopetal components of substantia innominata. Neuroscience. 1988;27:l-39.
138. Johnston JB. Further contributions to the study of the evo- bri lution of the forebrain. J Comp Neural. 1923;35:337-481.
139. Heimer L, Zahm DS, Churchill L, et al. Specificity in the projection patterns of accumbal core and shell in the rat. Neuroscience. 1991;41:89-125.
140. Hyytia P, Koob GF. GABAA receptor antagonism in the extended amygdala decreases ethanol self-administration in rats. Eur J Pharmacol. 1995;283:151-159.
141. Roberts AJ, Koob GF. Intra-amygdala muscimol decreases opérant ethanol self-administration in dependent rats. Alcohol Clin Exp Res. 1996;20:1289-1298.
142. Pontieri FE, Tanda G, Di Chiara G. Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. Proc NatlAcadSci USA. 1995;92:12304-12308.
143. Tanda G, Pontieri FE, Di Chiara G. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mul opioid receptor mechanism. Science. 1997;276:2048-2050.
144. Pontieri FE, Tanda G, Orzi F, Di Chiara G. Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature. 1996;382:255-257.
145. Merlo-Pich E, Lorang M, Yeganeh M, et al. Increase of extracellular corticotropin-releasing factor-like immunoreaclivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. / Neurosci. 1995;15:5439-S147.
146. Davis M. Neurobiology of fear responses: the role of the amygdala. J Neuropsychiatry Clin Neurosci. 1997;9:382-402.